Can trazodone and vortioxetine (Brintellix) be taken concomitantly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Trazodone and Vortioxetine Be Taken Together?

Yes, trazodone and vortioxetine can be taken concomitantly, but this combination requires careful monitoring due to the risk of serotonin syndrome, as both medications enhance serotonergic activity. 1

Risk of Serotonin Syndrome

The primary concern with combining these medications is serotonin syndrome, a potentially life-threatening condition that occurs when serotonergic medications are used together:

  • The FDA label for vortioxetine explicitly warns that the risk of serotonin syndrome increases with concomitant use of other serotonergic drugs, including trazodone. 1

  • Serotonin syndrome symptoms include mental status changes (agitation, hallucinations, confusion), autonomic instability (tachycardia, labile blood pressure, hyperthermia, diaphoresis), neuromuscular symptoms (tremor, rigidity, myoclonus, hyperreflexia), and gastrointestinal symptoms (nausea, vomiting, diarrhea). 2, 1

  • Symptoms typically arise within 24-48 hours after combining serotonergic medications or after dose increases. 2

Clinical Approach to Safe Combination Use

When prescribing these medications together, follow this structured approach:

  • Start the second medication at a low dose and increase slowly while monitoring closely for serotonin syndrome symptoms, especially during the first 24-48 hours after any dosage changes. 2

  • Inform patients about the increased risk of serotonin syndrome and instruct them to report any concerning symptoms immediately. 1

  • Monitor for additive sedative effects, as both medications can cause drowsiness—trazodone through its antihistaminic and alpha-1 adrenergic antagonism, and vortioxetine through its serotonergic effects. 3, 4

Pharmacological Considerations

  • Vortioxetine has a favorable drug interaction profile with minimal effects on cytochrome P450 enzymes, reducing the risk of pharmacokinetic interactions with trazodone. 5

  • Trazodone is metabolized primarily by CYP3A4, while vortioxetine is metabolized by multiple CYP enzymes including CYP2D6, making significant pharmacokinetic interactions unlikely. 3, 5

  • The combination may be clinically rational when treating depression with comorbid insomnia, as trazodone at lower doses (25-100 mg) provides hypnotic effects while vortioxetine addresses depression. 3, 6

Monitoring Requirements

  • Discontinue both medications immediately if signs of serotonin syndrome develop and initiate supportive symptomatic treatment. 1

  • Avoid combining with additional serotonergic agents (other antidepressants, tramadol, triptans, St. John's Wort, dextromethorphan) to minimize cumulative serotonergic effects. 2, 1

  • Monitor for increased bleeding risk, as vortioxetine (like other serotonin reuptake inhibitors) may increase bleeding events, particularly when combined with NSAIDs, aspirin, or anticoagulants. 1

Common Pitfalls to Avoid

  • Do not combine either medication with MAOIs, as this is contraindicated due to severe risk of serotonin syndrome. 2, 1

  • Avoid abrupt discontinuation of vortioxetine, particularly at doses of 15-20 mg/day, as this can cause discontinuation syndrome with symptoms including nausea, dizziness, irritability, and sensory disturbances. 1

  • Be cautious in elderly patients who may experience increased sedation and orthostatic hypotension from the combination. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Research

Antidepressant properties of trazodone.

Clinical pharmacy, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.